Horizon 2020 Health

SC1-BHC-09-2018: Innovation platforms for advanced therapies of the future

Deadline: April 18, 2018

Advanced therapies are based on gene, cell or tissue-engineered products which are defined and placed on the market according to the terms of Regulation 1394/2007. So far, only a small number of these products have been placed on the market, and of these, most are for rare diseases. However, in recent years, important discoveries and developments, some unprecedented, have been made in molecular and cell biology and in cell technology, which offer improved opportunities for advanced therapies development.

Building on European strengths and using the definition set out in Regulation (EC) 1394/2007, projects should create knowledge and exploitation platforms around innovative concepts for advanced therapy development.

Funds projects within:

The official call from Horizon 2020 Health

Can your project get funding from Horizon 2020 Health

Is this call a perfect match for your project? Contact us to discuss your possibilities within Horizon 2020 Health.

About Horizon 2020 Health

With support from Horizon 2020 Health you will be able to conduct international research projects in support of EU policies for health. Support will be given to projects aimed at: Health promotion and prevention; diagnosis improvement; innovative treatments and technologies; active and healthy aging; citizen-centered care; and improving health information etc.

More about the grant

We help you succeed

We help companies obtain public funding by converting good projects to well-prepared applications.

Our services cover the entire application process:

Identifying funding opportunities
We identifying your best funding opportunities
Planning and scoping your project
We plan and scope your project to meet demands
Writing the successful application
We write the application that increases your chance of success